Key Points
- Francis Nelson Shen made large insider purchases — 439,600 shares on Mar 24 at C$7.00 (C$3,077,200) and 50,000 shares on Mar 26 at C$6.99 (C$349,500), totaling about C$3.43M.
- Shares opened at C$6.95 (near the 52‑week low of C$6.67) and trade below the 50‑day (C$8.07) and 200‑day (C$9.32) moving averages, with a market cap of ~C$439M and a P/E of 69.5.
- Analysts maintain a consensus Buy rating with an average price target of C$13.86; Vitalhub last reported C$0.06 EPS on C$31.39M revenue and analysts forecast ~C$0.23 EPS for the year.
Vitalhub Corp. (TSE:VHI - Get Free Report) Director Francis Nelson Shen bought 50,000 shares of the firm's stock in a transaction on Thursday, March 26th. The shares were purchased at an average cost of C$6.99 per share, with a total value of C$349,500.00. Following the transaction, the director directly owned 50,000 shares in the company, valued at approximately C$349,500. This trade represents a ∞ increase in their position.
Francis Nelson Shen also recently made the following trade(s):
- On Tuesday, March 24th, Francis Nelson Shen purchased 439,600 shares of Vitalhub stock. The shares were purchased at an average price of C$7.00 per share, with a total value of C$3,077,200.00.
Vitalhub Stock Performance
Shares of TSE VHI opened at C$6.95 on Friday. The company's 50 day moving average price is C$8.07 and its 200-day moving average price is C$9.32. Vitalhub Corp. has a 52-week low of C$6.67 and a 52-week high of C$14.64. The company has a market capitalization of C$439.46 million, a P/E ratio of 69.50, a price-to-earnings-growth ratio of 1.18 and a beta of 0.65.
Vitalhub (TSE:VHI - Get Free Report) last posted its quarterly earnings data on Wednesday, March 18th. The company reported C$0.06 earnings per share for the quarter. Vitalhub had a net margin of 5.61% and a return on equity of 2.75%. The company had revenue of C$31.39 million during the quarter. Analysts forecast that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the company. Royal Bank Of Canada decreased their price target on Vitalhub from C$13.00 to C$12.00 and set an "outperform" rating for the company in a report on Monday, January 26th. Raymond James Financial cut their target price on Vitalhub from C$15.00 to C$11.00 and set an "outperform" rating on the stock in a research report on Tuesday. ATB Cormark Capital Markets decreased their target price on Vitalhub from C$16.50 to C$15.00 and set an "outperform" rating for the company in a research note on Tuesday, March 10th. Finally, Scotiabank lowered their target price on Vitalhub from C$15.00 to C$12.00 and set an "outperform" rating for the company in a report on Wednesday, February 4th. One investment analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company. Based on data from MarketBeat.com, Vitalhub presently has a consensus rating of "Buy" and an average price target of C$13.86.
Get Our Latest Report on Vitalhub
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
